IDL Diagnostics AB (FRA:80R) Cyclically Adjusted FCF per Share: €-0.02 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:80R IDL Diagnostics AB FRA:80R
55 GF Score
Price €0.03
GF Value €0.03
! 2 Warning Signs
View Full Analysis

What is IDL Diagnostics AB Cyclically Adjusted FCF per Share?

IDL Diagnostics AB FRA:80R +5.79% 55 Cyclically Adjusted FCF per Share is €-0.02 as of Mar. 2026. GuruFocus rates FRA:80R with a GF Score™ of 55/100 and a GF Value™ of €0.03. The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

IDL Diagnostics AB's adjusted free cash flow per share for the three months ended in Mar. 2026 was €0.001. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €-0.02 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2026-07-16), IDL Diagnostics AB's current stock price is €0.0256. IDL Diagnostics AB's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was €-0.02. IDL Diagnostics AB's Cyclically Adjusted Price-to-FCF of today is .


IDL Diagnostics AB  (FRA:80R) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


IDL Diagnostics AB Cyclically Adjusted FCF per Share Related Terms


IDL Diagnostics AB Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for IDL Diagnostics AB's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IDL Diagnostics AB Cyclically Adjusted FCF per Share Chart

IDL Diagnostics AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.03 -0.03 -0.02 -0.02 0.00

IDL Diagnostics AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.03 -0.03 -0.02 0.00 -0.02

FRA:80R vs TMO, DHR, IDXX: Cyclically Adjusted FCF per Share Comparison

For the Diagnostics & Research subindustry, IDL Diagnostics AB's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IDL Diagnostics AB Cyclically Adjusted Price-to-FCF vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, IDL Diagnostics AB's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where IDL Diagnostics AB's Cyclically Adjusted Price-to-FCF falls into.


FRA:80R
55GF Score
IDL Diagnostics AB FRA:80R
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

IDL Diagnostics AB Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, IDL Diagnostics AB's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.001/133.5600*133.5600
=0.001

Current CPI (Mar. 2026) = 133.5600.

IDL Diagnostics AB Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 -0.004 101.019 -0.005
201609 -0.003 101.138 -0.004
201612 -0.013 102.022 -0.017
201703 -0.017 102.022 -0.022
201706 -0.011 102.752 -0.014
201709 -0.015 103.279 -0.019
201712 -0.010 103.793 -0.013
201803 -0.010 103.962 -0.013
201806 -0.011 104.875 -0.014
201809 -0.011 105.679 -0.014
201812 -0.008 105.912 -0.010
201903 -0.010 105.886 -0.013
201906 -0.010 106.742 -0.013
201909 -0.006 107.214 -0.007
201912 -0.009 107.766 -0.011
202003 -0.007 106.563 -0.009
202006 -0.005 107.498 -0.006
202009 -0.018 107.635 -0.022
202012 -0.015 108.296 -0.018
202103 -0.008 108.360 -0.010
202106 -0.007 108.928 -0.009
202109 -0.021 110.338 -0.025
202112 -0.017 112.486 -0.020
202203 -0.005 114.825 -0.006
202206 -0.001 118.384 -0.001
202209 -0.005 122.296 -0.005
202212 -0.006 126.365 -0.006
202303 -0.002 127.042 -0.002
202306 -0.001 129.407 -0.001
202309 -0.002 130.224 -0.002
202312 0.000 131.912 0.000
202403 -0.002 132.205 -0.002
202406 0.001 132.716 0.001
202409 -0.002 132.304 -0.002
202412 0.001 132.987 0.001
202503 0.000 132.825 0.000
202506 -0.001 133.699 -0.001
202509 -0.002 133.480 -0.002
202512 0.000 133.390 0.000
202603 0.001 133.560 0.001

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of €-0.02 mean?
IDL Diagnostics AB (FRA:80R) has a Cyclically Adjusted FCF per Share of €-0.02 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on IDL Diagnostics AB and its competitors.
Is IDL Diagnostics AB's Cyclically Adjusted FCF per Share too high?
IDL Diagnostics AB's current Cyclically Adjusted FCF per Share is €-0.02. Overall, IDL Diagnostics AB has a GF Score™ of 55/100, reflecting its overall financial health beyond just this single metric.
How does IDL Diagnostics AB's Cyclically Adjusted FCF per Share compare to TMO and DHR?
IDL Diagnostics AB's Cyclically Adjusted FCF per Share of €-0.02 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Diagnostics & Research company?
A good Cyclically Adjusted FCF per Share depends on the Medical Diagnostics & Research industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on IDL Diagnostics AB and its competitors. IDL Diagnostics AB's current Cyclically Adjusted FCF per Share is €-0.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IDL Diagnostics AB stock overvalued right now?
IDL Diagnostics AB (FRA:80R) has a current Cyclically Adjusted FCF per Share of €-0.02. The stock's GF Value™ is €0.03, compared to a current price of €0.03 — trading 14.7% below its estimated fair value. The current Cyclically Adjusted FCF per Share is €-0.02. IDL Diagnostics AB's overall GF Score™ is 55/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For IDL Diagnostics AB (FRA:80R), the current Cyclically Adjusted FCF per Share is €-0.02 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is IDL Diagnostics AB (FRA:80R) Overvalued in 2026?

Based on GuruFocus' analysis, IDL Diagnostics AB stock appears to be undervalued. The current stock price of €0.03 is trading 14.7% below its estimated GF Value™ of €0.03.

Key valuation signals for FRA:80R:

  • Cyclically Adjusted FCF per Share: €-0.02
  • GF Value™: €0.03 vs. price of €0.03 (14.7% below fair value)
  • GF Score™: 55/100 with 2 warning signs

No single metric tells the full story. See the FRA:80R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


IDL Diagnostics AB Business Description

Other Exchanges IDLDX:Sweden
Address Karlsbodavagen 39, Bromma, Stockholm, SWE, 168 67
IDL Diagnostics AB is a Swedish company that develops and markets blood and urine sample tests. It specializes in oncology and bacteriology. The company has a broad product portfolio, is used in healthcare, and is established in various markets. In oncology, IDL Diagnostics uses various biomarkers, TK1 and cytokeratins, to support the treatment of cancers such as breast, prostate, and bladder cancers.
55GF Score

Get the complete analysis for FRA:80R

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.03
Price
€0.03
GF Value